目的 探讨高促甲状腺素(TSH)血症患儿的治疗、转归及其影响因素,为临床治疗、随访提供参考依据。方法 2012-2014年两年在本院诊断为高TSH血症的新生儿,第一次复查甲状腺功能显示TSH≥15 mU/L者进行药物治疗,TSH(6.27～15 mU/L)者不服药为随访组,以10为切值将随访组分成两组进行随访。结果 两组高TSH血症患儿的智能、身长发育差异无统计学意义,两组的自然转归结果差异亦无统计学意义,随访组中约80%高TSH血症患儿甲状腺功能在半岁以内可恢复正常。结论 1)TSH＜15 mU/L的高TSH血症患儿其甲状腺功能约84.9%可自行正常恢复。2)对于10 mU/L ≤TSH＜15 mU/L高TSH血症患儿选择治疗时应综合考虑。
Abstract
Objective To investigate the treatment,outcome and influencing factors of neonatal hyperthyrotropinemia and improve the treatment and follow-up level of hyperthyrotropinemia. Methods Neonates were diagnosed hyperthyrotropinemia in 2012~2014.Some were treated with drug whose concentration of thyrotropin were greater than 15 mU/L.The others were followed up whose concentration of thyrotropin were 6.27～15 mU/L.The follow-up group were splited into two groups with a tangent of 10. Results Two follow-up groups with hyperthyrotropinemia had no significant differences in intelligence,length and natural outcome.The thyroid function of about 80% neonates with hyperthyrotropinemia returned to normal within 6 months. Conclusions 1)84.9% neonates are back to normal on their own whose concentration of thyrotropin are less than 15 mU/L.2)Treatment for neonates should be considered comprehensively whose concentration of thyrotropin are 10~15 mU/L.
关键词
高TSH血症 /
转归 /
治疗时机
Key words
hyperthyrotropinemia /
outcome /
treatment time
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 中华医学会儿科学会内分泌遗传代谢学组.先天性甲状腺功能减低症诊疗共识[J].中华儿科杂志,2011,49(6):421-423.
[2] 陈肖肖,秦玉峰,周雪莲,等.婴幼儿亚临床甲状腺功能减退症的诊断标准和治疗探讨[C].2007年全国儿童保健学术会议论文集,2007:132-136.
[3] 李玉芬,张立琴,胡晓燕.新生儿高促甲状腺素血症446例临床转归研究[J].中国儿童保健杂志,2013,21(2):125-126.
[4] 周雪莲,黄晓磊,童凡,等.新生儿高促甲状腺素血症转归研究[J].中国儿童保健杂志,2012,20(3):256-258.
[5] 文玮,黄晓春,伍小秋,等.新生儿先天性亚临床甲状腺功能降低症的随访观察[J].中国优生与遗传杂志,2007,15(8):83-84.
[6] 腾卫平.开展亚临床甲状腺功能减退症的临床研究[J].中华内分泌代谢杂志,2004,20(2):93-95.
[7] Leitner AY,Pellegrini F,Beck-Peccoz P.The natueal history of the hyperthrotropinemia of children born prematurely[J].J Endocrinol Invest,2012,35(3):260-264.
[8] Simonsick EM,Newman AB,Ferrucci L,et al.Subclinical hypothyroidism and functional mobility in older adults[J].Arch Intern Med,2009,169(21):2011-2017.
[9] Teixeira PF,Cabral MD,Silva NA,et al.Serum leptin in overt and subclinical hypothyroidism:effect of levothyroxine treatment and relationship to menopausal status and body composition[J].Thyroid,2009,19(5):443-450.
[10] Rodondi N,Bauer DC,Cappola AR,et al.Subclinical thyroid dysfunction,cardiac function,and the risk of heart failure.The Cardiovascular Health study[J].Int J Am Coll Cardio,2008,52(14):1152-1159.
基金
长沙市科技局立项项目(K10ZD035-13)
PDF(413 KB)
